latest news releases from the newsroom
Oasmia Pharmaceutical AB
The terms and price of the new convertible instruments will be determined
through an accelerated book building procedure and the closing price of the
Company’s shares on Nasdaq Stockholm on 30 March 2017.
The Company intends to use the proceeds from the Private Placement to
strengthen its working capital as well as finance its continuing operations.
The Board of Directors has determined, given the phase the Company is currently
in, that this financing will give it time to finalize certain
OmniComm Systems Inc.
Record Revenue and Operating Income